AS085 - Twelve-month interim analysis of efficacy and safety of givosiran, an investigational RNAi therapeutic for acute hepatic porphyria, in the envision open label extension

Autor:	Sardh, Eliane, Balwani, Manisha, Rees, David, Stein, Penelope, Stözel, Ulrich, Aguilera, Paula, Bissell, D. Montgomery, Bonkovsky, Herbert, Keel, Sioban, Parket, Charles, Phillips, John, Silver, Samuel, Windyga, Jerzy, D’Avola, Delia, Ross, Gayle, Stewart, Peter, Ritchie, Bruce, Harper, Pauline, Wang, Jiaan-Der, Langendonk, Janneke Langendonk, Ivanova, Aneta, Horie, Yutaka, Anderson, Karl, Ventura, Paolo, Cappellini, Maria Domenica, Vassiliou, Daphne, Monroy-Santoyo, Susana, Petrides, Petro, Adachi, Tomohide, Kuter, David, Scalera, Sushama, Penz, Craig, Liu, Gary, Ko, John, Simon, Amy, Gouya, Laurent
Zdroj:	In Journal of Hepatology August 2020 73 Supplement 1:S62-S63
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect